drugset / Trial / NCT02997176
An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a trial to investigate the pharmacokinetics (PK) and the safety of talazoparib in patients with advanced solid tumors and impaired hepatic function.
Timeline
- Start
- 2016-09-30
- Primary completion
- 2020-02-12
- Completion
- 2020-02-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Talazoparib | Small molecule | 0.5 mg | Oral |